Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, Virginia.
Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Gastroenterology. 2022 Oct;163(4):1107-1114. doi: 10.1053/j.gastro.2022.07.079. Epub 2022 Aug 22.
The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Review is to provide practical, evidence-based guidance to clinicians regarding the role of endoscopy for recurrent acute and chronic pancreatitis.
This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide guidance on a topic of clinical importance to the AGA membership, underwent internal peer review by the Clinical Practice Updates Committee (CPUC), and external peer review through standard procedures of Gastroenterology. This review is framed around the 8 best practice advice points agreed upon by the authors, based on the results of randomized controlled trials, observational studies, systematic reviews and meta-analyses, as well expert consensus in this field. Best Practice Advice Statements BEST PRACTICE ADVICE 1: After an unrevealing initial evaluation, endoscopic ultrasound is the preferred diagnostic test for unexplained acute and recurrent pancreatitis. Magnetic resonance imaging with contrast and cholangiopancreatography is a reasonable complementary or alternative test to endoscopic ultrasound, based on local expertise and availability. BEST PRACTICE ADVICE 2: The role of endoscopic retrograde cholangiopancreatography (ERCP) for reducing the frequency of acute pancreatitis episodes in patients with pancreas divisum is controversial, but minor papilla endotherapy may be considered, particularly for those with objective signs of outflow obstruction, such as a dilated dorsal pancreatic duct and/or santorinicele. There is no role for ERCP to treat pain alone in patients with pancreas divisum. BEST PRACTICE ADVICE 3: The role of ERCP for reducing the frequency of pancreatitis episodes in patients with unexplained recurrent acute pancreatitis and standard pancreatic ductal anatomy is controversial and should only be considered after a comprehensive discussion of the uncertain benefits and potentially severe procedure-related adverse events. When pursued, ERCP with biliary sphincterotomy alone may be preferable to dual sphincterotomy. BEST PRACTICE ADVICE 4: Surgical intervention should be considered over endoscopic therapy for long-term treatment of patients with painful obstructive chronic pancreatitis. Endoscopic intervention is a reasonable alternative to surgery for suboptimal operative candidates or those who favor a less invasive approach, assuming they are clearly informed that the best practice advice primarily favors surgery. BEST PRACTICE ADVICE 5: When ERCP is pursued, small (≤5mm) main pancreatic duct stones can be treated with pancreatography and conventional stone extraction maneuvers. For larger stones, extracorporeal shockwave lithotripsy and/or pancreatoscopy with intraductal lithotripsy may be required. BEST PRACTICE ADVICE 6: When ERCP is pursued, prolonged stent therapy (6-12 months) is effective for treating symptoms and remodeling main pancreatic duct strictures. The preferred approach is to place and sequentially add multiple plastic stents in parallel (upsizing); emerging evidence suggests that fully covered self-expanding metal stents may have a role for this indication, but additional research is necessary. BEST PRACTICE ADVICE 7: ERCP with stent insertion is the preferred treatment for benign biliary stricture due to chronic pancreatitis. FCSEMS placement is favored over multiple plastic stents whenever feasible, given similar efficacy but significantly reduced need for stent exchange procedures during the treatment course. BEST PRACTICE ADVICE 8: Celiac plexus block should not be routinely performed for the management of pain due to chronic pancreatitis. The decision to proceed with celiac plexus block in selected patients with debilitating pain in whom other therapeutic measures have failed can be considered on a case-by-case basis, but only after discussion of the unclear outcomes of this intervention and its procedural risks.
本美国胃肠病学协会(AGA)临床实践更新专家评论的目的是为临床医生提供有关内镜在复发性急性和慢性胰腺炎中的作用的实用、基于证据的指导。
本专家评论由 AGA 研究所临床实践更新委员会和 AGA 理事会委托和批准,旨在为 AGA 会员关注的重要临床主题提供指导,经过临床实践更新委员会(CPUC)的内部同行评审,并通过标准程序进行外部同行评审。胃肠病学。本评论围绕作者根据随机对照试验、观察性研究、系统评价和荟萃分析以及该领域的专家共识得出的 8 个最佳实践建议点构建。
最佳实践建议 1:在初始评估无明显结果后,对于不明原因的急性和复发性胰腺炎,超声内镜是首选的诊断测试。基于当地专业知识和可用性,磁共振成像(MRI)联合造影和胰胆管造影是内镜超声的合理补充或替代测试。
最佳实践建议 2:内镜逆行胰胆管造影术(ERCP)在治疗胰腺分裂症患者中减少急性胰腺炎发作频率的作用存在争议,但可以考虑乳头内切开术,特别是对于那些有明确的流出道梗阻迹象的患者,例如扩张的背胰管和/或胰管憩室。ERCP 不应仅用于治疗胰腺分裂症患者的疼痛。
最佳实践建议 3:对于不明原因的复发性急性胰腺炎和标准胰管解剖结构的患者,ERCP 减少胰腺炎发作频率的作用存在争议,只有在全面讨论不确定的益处和潜在严重的与手术相关的不良事件后,才应考虑 ERCP。当进行 ERCP 时,单独进行胆管括约肌切开术可能比双重括约肌切开术更可取。
最佳实践建议 4:对于有疼痛性梗阻性慢性胰腺炎的患者,应考虑手术干预而不是内镜治疗。对于不太适合手术的患者或那些倾向于采用侵袭性较小方法的患者,内镜干预是手术的合理替代方法,假设他们明确了解主要有利于手术的最佳实践建议。
最佳实践建议 5:当进行 ERCP 时,较小的(≤5mm)主胰管结石可以通过胰管造影和常规结石提取操作进行治疗。对于较大的结石,可能需要体外冲击波碎石术和/或胰管内碎石术。
最佳实践建议 6:当进行 ERCP 时,延长支架治疗(6-12 个月)可有效治疗症状和重塑主胰管狭窄。首选方法是放置并顺序添加多个平行的塑料支架(逐渐增大);新出现的证据表明,完全覆盖的自膨式金属支架可能在该适应证中有一定作用,但需要进一步研究。
最佳实践建议 7:对于因慢性胰腺炎引起的良性胆管狭窄,ERCP 联合支架置入是首选的治疗方法。只要可行,应优先使用 FCSEMS 放置而不是多个塑料支架,因为在治疗过程中,支架交换程序的需求明显减少。
最佳实践建议 8:对于慢性胰腺炎引起的疼痛,不应常规进行腹腔神经丛阻滞。对于其他治疗措施失败后患有严重疼痛的选定患者,可以考虑在个案基础上进行腹腔神经丛阻滞,但仅在讨论该干预措施的不确定结果及其程序风险后。